Hadassah Southeastern includes nearly 6000 members and supporters throughout Georgia, South Carolina and western North Carolina. Hadassah provides tangible ways to engage in tikkun olam – in your community, in Israel, throughout the U.S. and the world – and helps strengthen your connection with other Jewish women. We encourage personal growth through our events and volunteer opportunities, while inspiring a passion for and commitment to our partnership with the land and people of Israel.
P : 678.443.2961
c/o Hadassah Hub: Super South
1050 Crown Pointe Parkway, Suite 500
Atlanta, Georgia 30338
Hadassah Southeastern Event Calendar 2020
All events are subject to change. Please check with your local Region/Chapter/Group.
Hadassah Dedicates New Lab to Defeat Zika Virus
Prof. Dana Wolf, head of the Clinical Virology Unit in the Dept. of Clinical Microbiology and Infectious Diseases at the Hadassah Medical Center, is a world-renowned specialist in viruses and the damage they can cause to unborn babies. Responding to global anxiety about the Zika virus, Prof. Wolf and her staff recently opened a new laboratory dedicated to defeating it. The Zika virus, she says, “is dangerous in the interface between mother and unborn child.”
According to Prof. Wolf, Zika, like Rubella, can cause a variety of serious birth defects. Rubella, however, once a threatening virus that plagued the Western world, has now been taken care of through vaccination. The two viruses differ, though, in that unlike Rubella, Zika is transmitted by mosquitoes, like the Dengue virus. Dengue, however, though in the same family as Zika, is not associated with birth defects.
Hadassah, under the direction of Prof. Benjamin Reubinoff, head of its Human Embryonic Stem Cell Research Center, has been conducting research on a more dangerous virus called cytomegalovirus (CVM), which remains in our bodies forever. Hadassah research has revealed the attack pattern of the virus, which strikes the fetus just as nerve cells are being developed. Prof. Wolf and her staff will apply the tools to Zika that were developed by Hadassah to study CMV. "We have had so many requests for help that we decided to work on this," said Prof. Wolf, who reports that Hadassah received the virus for research from the United States Centers for Disease Control and Prevention.
Hadassah-Developed Blood Test Detects Multiple Sclerosis, Cancer & Brain Damage
A new blood test that uses the DNA strands of dying cells to detect diabetes, cancer, traumatic brain injury, and neurodegenerative disease has been developed by researchers at Hadassah Medical Organization (HMO) and The Hebrew University.
In a study involving 320 patients, the researchers were able to infer cell death in specific tissues by looking at the unique chemical modifications (called methylation patterns) of circulating DNA that these dying cells release. Previously, it had not been possible to measure cell death in specific human tissues non-invasively.
Full article available here.
Photo from L to R:
Hadassah Southeastern's own Dr. Rachel Schonberger, Hadassah HMO Chair,
Dr. Dimitrios Karussis, MD, PhD, Senior Neurologist, HMO, JAMA Neurology Study Principal Investigator;
Chaim Lebovits, President & CEO, BrainStorm Cell Therapeutics
Eropean Union Awards 4 million dollars for Human Trials with Revolutionary cardiac imaging PET agent developed by Hadassah Medical Organization researchers
The novel cardiac imaging technology will reduce the need for exploratory heart procedures. A project pioneered and led by Professor Eyal Mishani and the Cyclotron and Radiochemistry Unit he heads at Hadassah Hospital have awarded a 4 million dollar research and development grant from the European union's Horizon 2020 program to begin human-trials in a new cardiac PET/CT tracer which is expected to cut the need for exploratory heart catheterization. There are more than a million diagnostic heart catheterizations in the United States every year, less than half of which show heart problems which require further treatment. Hadassah Medical Organization is the only hospital in the world to have this imaging agent, invented in the Hadassah laboratory. This radioactive substance -when injected in patients-accumulates in the heart and can lead to blood flow measurement to the heart non-invasively. The invention of this imaging agent heralds a new stage in the diagnosis of cardiovascular disease, the leading cause of death in the world.
A Picture is Worth a Thousand Words!
Over 70 Hadassah members and Associates from the Southeastern Region visited Israel in October 2012 for the national Hadassah Convention. Watch this slideshow for a glimpse of the fun had by all.
Sign-up for our Emails:
Education/Public Policy VP/Coor
Amer Affairs/Domestic Policy
Membership/Outreach VP/Area VP/Advisor
Annual Giving Chair